Microbot Medical Inc (MBOT) concluded trading on Thursday at a closing price of $2.43, with 3.45 million shares of worth about $8.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 144.07% during that period and on April 24, 2025 the price saw a gain of about 16.83%. Currently the company’s common shares owned by public are about 34.74M shares, out of which, 31.69M shares are available for trading.
Stock saw a price change of -1.22% in past 5 days and over the past one month there was a price change of 52.83%. Year-to-date (YTD), MBOT shares are showing a performance of 116.96% which increased to 173.80% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.82 but also hit the highest price of $3.38 during that period. The average intraday trading volume for Microbot Medical Inc shares is 3.05 million. The stock is currently trading 28.27% above its 20-day simple moving average (SMA20), while that difference is up 41.18% for SMA50 and it goes to 87.47% higher than SMA200.
Microbot Medical Inc (NASDAQ: MBOT) currently have 34.74M outstanding shares and institutions hold larger chunk of about 6.91% of that.
The stock has a current market capitalization of $84.43M and its 3Y-monthly beta is at 1.07. It has posted earnings per share of -$0.73 in the same period. It has Quick Ratio of 2.37 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MBOT, volatility over the week remained 13.91% while standing at 14.64% over the month.
Stock’s fiscal year EPS is expected to rise by 45.21%.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on January 13, 2020 offering a Buy rating for the stock and assigned a target price range of between $12 and $26 to it. Coverage by H.C. Wainwright stated Microbot Medical Inc (MBOT) stock as a Buy in their note to investors on December 24, 2019, suggesting a price target of $12 for the stock.
